Friday, April 24, 2026 | 02:30 PM ISTहिंदी में पढें
Bafna Pharmaceuticals Ltd
Board Meeting Intimation for Approval Of Q1 FY24 Financial Results.
03:39 PM, 3rd Aug 2023
BAFNA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2023 inter alia to consider and approve the Un-Audited Standalone Financial Results of the Company for the first quarter of FY24 ended June 30 2023 together with the Limited Review Report for the said period.